AOD-9604 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-11-04 and is reviewed periodically as new material appears.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
In the summer of 1923, the Proletarian Sports Society "Dynamo" was established in Moscow as a sports organization of the Soviet secret police Cheka. On 13 July 1925 the Central Committee of the Russian Communist Party (Bolsheviks) adopted a statement "About the party's tasks in sphere of physical culture". In the statement was determined the role of physical culture in Soviet society and the party's tasks in political leadership of physical culture movement in the country. The Soviet Olympic Committee formed on 21 April 1951, and the IOC recognized the new body in its 45th session. In the same year, when the Soviet representative Konstantin Andrianov became an IOC member, the USSR officially joined the Olympic Movement. The 1952 Summer Olympics in Helsinki thus became first Olympic Games for Soviet athletes. The Soviet Union was the biggest rival to the United States at the Summer Olympics, winning six of its nine appearances at the games and also topping the medal tally at the Winter Olympics six times. The Soviet Union's Olympics success has been attributed to its large investment in sports to demonstrate its superpower image and political influence on a global stage. The Soviet Union national ice hockey team won nearly every world championship and Olympic tournament between 1954 and 1991 and never failed to medal in any International Ice Hockey Federation (IIHF) tournament in which they competed. The Soviet Olympic team was notorious for skirting the edge of amateur rules.
== Procedure == One or more subjects (usually, pilots or crew members, though anyone interested in the effects of high altitude can usually arrange a visit) are placed in the chamber. Before "ascending" to the desired altitude, subjects breathe oxygen from oxygen masks to purge nitrogen from their bloodstream so decompression sickness (DCS) does not occur. With masks in place, the atmospheric pressure inside the chamber is then reduced to simulate altitudes of up to tens of thousands of feet. The subjects then remove their oxygen masks and experience the symptoms of hypoxia. An inside safety observer, breathing oxygen by mask, should always be present to place a subject's mask back on in the event a subject passes out unconscious. Outside observers monitor the subjects' condition via closed circuit television and viewing ports. While the masks are off, subjects may be asked to do trivial tasks, such as arithmetic and signing their own names. When such tasks start taking excessive lengths of time to be done or are done poorly, it is usually a sign that the "time of useful consciousness" has been exceeded and that the masks should be replaced. Subjects may also ensure that they are able to do tasks such as clear their nose and sinuses easily, as pain from such problems can be a major distraction in an emergency such as rapid decompression.
The maximum absorption of light is near 670 nm. The specifics of absorption depend on several factors, including protonation, adsorption to other materials, and metachromasy – the formation of dimers and higher-order aggregates depending on concentration and other interactions:
Sources: en.wikipedia.org
In hemodialysis, the patient's blood is pumped through the blood compartment of a dialyzer, exposing it to a partially permeable membrane. The dialyzer is composed of thousands of tiny hollow synthetic fibers. The fiber wall acts as the semipermeable membrane. Blood flows through the fibers, dialysis solution flows around the outside of the fibers, and water and wastes move between these two solutions. The cleansed blood is then returned via the circuit back to the body. Ultrafiltration occurs by increasing the hydrostatic pressure across the dialyzer membrane. This usually is done by applying a negative pressure to the dialysate compartment of the dialyzer. This pressure gradient causes water and dissolved solutes to move from blood to dialysate and allows the removal of several litres of excess fluid during a typical 4-hour treatment. In the United States, hemodialysis treatments are typically given in a dialysis center three times per week (due in the United States to Medicare reimbursement rules); however, as of 2005 over 2,500 people in the United States are dialyzing at home more frequently for various treatment lengths. Studies have demonstrated the clinical benefits of dialyzing 5 to 7 times a week, for 6 to 8 hours. This type of hemodialysis is usually called nocturnal daily hemodialysis and a study has shown it provides a significant improvement in both small and large molecular weight clearance and decreases the need for phosphate binders.
The initial force of 500 armed Huks which was organized into five squadrons had increased to a fully armed guerrilla force of 20,000 men. By 1944, Huk strength numbers at 76 squadrons. After the Cabiao raid by the Japanese, the PKP adopted a "retreat for defense" policy, which broke up squads to smaller groups of three to five men. In areas controlled by Huk guerrillas, the Huks organized an ad-hoc police force to keep the peace and stop looters and thieves. Huks also formed Sandatahang Tanod ng Bayan (Barrio United Defense Corps), which acted as neighborhood governments in support of the Huk forces in the field. These BUDC's were composed of KPMP and AMT members, which organized popular support for Huks, shielded harvest from the Japanese, and attacked Filipino collaborators; in effect, setting up protected zones and safe havens for the Huks. The Hukbalahap also set-up a government, composed of a President, Vice-President, Secretary, Treasurer, and five policemen. The barrio government also had three departments, with a person-in-charge leading it. One department collected intelligence information about the military, another handled communication between different barrios and Huk members, and the third arranged for supplies. The Hukbalahap government also performed civil tasks, such as officiating in weddings, baptisms, funerals, and issued marriage licenses and birth certificates.
The god Hermes provides the male character Trygaios a female companion; when Trygaios asks if there would be a problem if she became pregnant, Hermes responds, "Not if you add a dose of pennyroyal." In a similar manner, in Aristophanes' comedy Lysistrata, after a pregnant female character on stage is told to withhold her body sexually from her husband, a slender female character, in comparison to the pregnant woman, is described as "a very lovely land Well croppy, and trimmed and spruced with pennyroyal." Early settlers in colonial Virginia used dried pennyroyal to eradicate pests. Pennyroyal was such a popular herb that the Royal Society published an article on its use against rattlesnakes in the first volume of its Philosophical Transactions in 1665. 17th-century apothecary and physician Nicholas Culpeper mentions pennyroyal in his medical text The English Physitian, published in 1652. In addition to its abortive properties, Culpeper recommends its use for gastrointestinal ailments, such as constipation and hemorrhoids, as well as itching and blemishes to the skin, and even toothaches. Pennyroyal is an essential ingredient in the North African dish, which is still eaten to this day, called Batata fliou. Pennyroyal continues to be used up through the 20th and 21st centuries. Its oil is still commercially available today, though little is known about the appropriate dosages for humans. Scientists therefore likely consider it unsafe for use, as it is potentially toxic.
==== Monoubiquitylation ==== Monoubiquitylation is the addition of one ubiquitin molecule to one substrate protein residue. Multi-monoubiquitylation is the addition of one ubiquitin molecule to multiple substrate residues. The monoubiquitylation of a protein can have different effects to the polyubiquitylation of the same protein. The addition of a single ubiquitin molecule is thought to be required prior to the formation of polyubiquitin chains. Monoubiquitylation affects cellular processes such as membrane trafficking, endocytosis and viral budding.
Sources: en.wikipedia.org
Black pepper (Piper nigrum) is a flowering vine in the family Piperaceae, cultivated for its fruit (the peppercorn), which is usually dried and used as a spice and seasoning. The fruit is a drupe (stonefruit) which is about 5 mm (1⁄4 in) in diameter (fresh and fully mature), dark red, and contains a stone which encloses a single pepper seed. Peppercorns and the ground pepper derived from them may be described simply as pepper, or more precisely as black pepper (cooked and dried unripe fruit), green pepper (dried unripe fruit), or white pepper (ripe fruit seeds). Black pepper is native to South Asia. Ground, dried, and cooked peppercorns have been used since antiquity, both for flavour and as a traditional medicine. Black pepper is one of the most commonly traded spices in the world. Its spiciness is due to the chemical compound piperine, which is a different kind of spiciness from that of capsaicin characteristic of chilli peppers. It is ubiquitous in the Western world as a seasoning and is often paired with salt and available on dining tables in shakers or mills.
== Documentaries == On 18 August 2023, BBC One broadcast the Panorama documentary Lucy Letby: The Nurse Who Killed, based on reporting by Judith Moritz. In 2024, Channel 5 released two documentaries Lucy Letby: Did She Really Do It? and Letby: The New Evidence. That same year, Moritz and Jonathan Coffey published Unmasking Lucy Letby: The Untold Story of the Killer Nurse. In 2025, ITV broadcast Lucy Letby: Beyond Reasonable Doubt?, while Channel 4 aired two series: Conviction: The Case of Lucy Letby and Lucy Letby: Murder or Mistake. In 2026, Netflix released a feature-length documentary titled The Investigation of Lucy Letby.
As early as 1929, the tuberculostearic acid, molecular formula C19H38O2) was discovered, which was isolated from the tuberculosis pathogen Mycobacterium tuberculosis. In analogy to its name, the biochemists suggested the English name 'lactobacillic acid', as the fatty acid originated from a Lactobacillus species. Lactobacillic acid has also been isolated from L. casei. In the publication, the scientists emphasized the implications of their discovery, which contradicted the opinion at the time that only fatty acids with an even number of carbon atoms occur in nature.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.